Antioxidants and cancer III: Quercetin

Alternative Medicine Review

Volumn 5, Issue 3, 2000, Pages 196-208

  Lamson, Davis W ^a,b,c   Brignall, Matthew S ^b  

^a Tahoma Clinic   (United States)

^b BASTYR UNIVERSITY   (United States)

^c Tahoma Clinic in Kent ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HEAT SHOCK PROTEIN; QUERCETIN; RAS PROTEIN;

ABSORPTION; ANTINEOPLASTIC ACTIVITY; BIOAVAILABILITY; CELL CYCLE G1 PHASE; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG SAFETY; GROWTH INHIBITION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVIEW; TUMOR GROWTH; DOWN REGULATION; HUMAN; NEOPLASM;

ABSORPTION; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; DOWN-REGULATION; HUMANS; NEOPLASMS; QUERCETIN;

EID: 0034202211     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Cody V, ed. Plant Flavonoids in Biology and Medicine. Prog Clin Biol Res 1986;213.
2. Cody V, ed. Plant Flavonoids in Biology and Medicine, part II. Prog Clin Biol Res 1988;280.
3. NTP Technical Report (no.409) on the toxicology and carcinogenesis studies of quercetin in F344/N rats. NIH Publication No. 91-3140 (1991). U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Research Triangle Park, NC.
4. Murray CW, Booth AN, DeEds F, Jones FT. Absorption and metabolism of rutin and quercetin in the rabbit. Am J Pharm Assoc 1954;43:361-364.
5. Nielsen SE, Kall M, Justesen U, et al. Human absorption and excretion of flavonoids after broccoli consumption. Cancer Lett 1997;114:173-174.
6. Morand C, Crespy V, Manach C, et al. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 1998;275:R212-R219.
7. Hollman PCH, Gaag MVD, Mengelers MJB, et al. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Rad Biol Med 1996;21:703-707.
8. Hollman PCH, de Vries JHM, van Leeuwen SD, et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62:1276-1282.
9. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 1995;33:1061-1080.
10. Quercetin (Monograph). Altern Med Rev 1998;3:140-143.
11. Hollman PCH, van Trijp JMP, Mengelers MJB, et al. Unavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 1997;114:139-140.
12. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975;9:229-234.
13. Ferry DR, Smith A, Malkhandi J, et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 1996;2:659-668.
14. Bjeldanes LF, Chang GW. Mutagenic activity of quercetin and related compounds. Science 1977;197:577-578.
15. Nakayasu M, Sakamoto H, Terada M, et al. Mutagenicity of quercetin in Chinese hamster lung cells in culture. Mutat Res 1986;174:79-83.
16. Duthie SJ, Johnson W, Dobson VL. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutat Res 1997;390:141-151.
17. Crebelli R, Aquilina G, Falcone E, Carere A. Urinary and faecal mutagenicity in Sprague-Dawley rats dosed with the food mutagen quercetin and rutin. Food Chem Toxicol 1987;25:9-15.
18. Ambrose AM, Robbins DJ, DeEds F. Comparative toxicities of quercetin and quercitrin. J Am Pharm Assoc 1952;41:119-122.
19. Hirono I, Ueno I, Hosaka S, et al. Carcinogenicity examination of quercetin and rutin in ACI rats. Cancer Lett 1981;13:15-21.
20. Morino K, Matsukura N, Kawachi T, et al. Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration. Carcinogenesis 1982;3:93-97.
21. Wilson RH, Mortarotti TG, Doxtader EK. Toxicity studies on rutin. Proc Soc Exp Biol Med 1947;64:324-327.